How much does it cost to take Ensartinib for one month?

Ensartinib is an ALK inhibitor independently developed in my country. It is mainly used to treat patients with ALK-positive locally advanced or metastatic non-small cell lung cancer (NSCLC). Compared with the first-generation drug crizotinib, ensartinib has certain advantages in penetrating the central nervous system and delaying the progression of drug resistance. As a domestically produced targeted drug, ensartinib not only has clear efficacy, but is also more affordable, making it a more accessible treatment option for Chinese patients.

The common specifications of ensartinib currently on the market are 75mg/ tablets, and each box is usually 56 tablets. Take the recommended dose of 225 mg per day (ie 3 tablets per day), and one box of medicine can be used for about 18 days. Typically patients require approximately two boxes of medication a month to maintain treatment. Compared with imported drugs, ensartinib has a simple medication method and stable dosage, making it easier for patients to use and manage it for a long time.

In terms of price, the price of each box of ensartinib is approximately 1,000 multiple RMB, which varies slightly depending on the region and channel. If two boxes are used per month, the patient's monthly drug cost ranges from 2,000 yuan to 3,000 yuan. More importantly, the drug has been included in the national medical insurance catalog, and patients who meet the reimbursement conditions can enjoy medical insurance reductions and exemptions in proportion, further reducing the actual burden.

In general, ensartinib not only has certain advantages in efficacy, but also has a relatively reasonable price. It is especially suitable for patients with ALK positive lung cancer who require long-term maintenance targeted therapy. For patients who do not have the financial conditions to afford imported drugs for a long time, ensartinib provides a cost-effective alternative that helps improve the continuity of treatment and quality of life.

Reference materials:https://www.drugs.com/